S. 865 · 113th Congress
Accelerating the End of Breast Cancer Act of 2013
Key: what the circles and colors mean
Each circle is a bill. The ring fills as it moves through Congress:
Under the number: the Yea · Nay count of its final (or latest) recorded vote. On a member's page, the small badge is how that member voted: Y Yea / Aye, N Nay / No, P Present, – Not voting.
Gold and violet are only for Yea and Nay; they never mean a party. A member's party is the letter on their photo.
Never voted on. It didn't reach a floor vote before the 113th Congress ended, so it expired. A bill has to be introduced again to be considered in a new Congress.
D
WhitehouseSponsor37 cosponsors · 28 D, 7 R, 2 I
D
Brown
MB
D
Begich
BC
D
Casey
AF
D
Franken
CG
R
Grassley
DH
R
Heller
JR
D
Reed
MW
D
Warner
RB
R
Blunt
SC
R
Collins
KA
R
Ayotte
FL
D
Lautenberg
CS
D
Schumer
JS
D
Shaheen
BB
D
Boxer
RB
D
Blumenthal
KG
D
Gillibrand
AK
D
Klobuchar
LM
R
Murkowski
ML
D
Landrieu
EW
D
Warren
AK
I
King
CM
D
Murphy
DF
D
Feinstein
TB
D
Baldwin
BM
D
Menendez
EM
D
Markey
JM
D
Merkley
BS
I
Sanders
DS
D
Stabenow
CB
D
Booker
RD
D
Durbin
MK
R
Kirk
BC
D
Cardin
CC
D
Coons
TJ
D
Johnson
PL
D
Leahy8 signed on when it was introduced; the rest joined later. Cosponsors who withdrew aren't shown.
Accelerating the End of Breast Cancer Act of 2013 - Establishes the Commission to Accelerate the End of Breast Cancer to help end breast cancer by January 1, 2020.
What it does: CRS summary · Introduced in Senate · May 6, 2013
Accelerating the End of Breast Cancer Act of 2013 - Establishes the Commission to Accelerate the End of Breast Cancer to help end breast cancer by January 1, 2020.
Directs the Commission to identify, recommend, and promote initiatives, partnerships, and research within the public and private sectors, basic and applied sciences, and epidemiology that can be turned into strategies to prevent breast cancer and breast cancer metastasis while giving priority to those that are: (1) not prioritized within the public sector, and (2) unlikely to be achieved by the private sector due to technical and financial uncertainty.
Requires the Commission to: (1) submit within six months to the President and to the relevant congressional committees a description of the Commission's strategic plan; (2) submit an annual report to the President, Congress, and the public; and (3) ensure that its activities are coordinated with, and do not duplicate the efforts of, programs and laboratories of other government agencies.
Directs the President to enter into an agreement with the Institute of Medicine to evaluate the Commission's progress.
Terminates the Commission on June 1, 2020.
Written by the nonpartisan Congressional Research Service. All summary versions on Congress.gov
About this bill and sources
Official title: Accelerating the End of Breast Cancer Act of 2013
Latest action (May 6, 2013): Read twice and referred to the Committee on Health, Education, Labor, and Pensions.
Policy area: Health · Origin: Senate · Introduced: May 6, 2013
Official page on Congress.gov · Bill text (GovInfo) · Status record (XML)
No recorded floor vote found.